| First Author | Luan P | Year | 2018 |
| Journal | FASEB J | Volume | 32 |
| Issue | 2 | Pages | 1070-1084 |
| PubMed ID | 29070585 | Mgi Jnum | J:270302 |
| Mgi Id | MGI:6277671 | Doi | 10.1096/fj.201700511RR |
| Citation | Luan P, et al. (2018) NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation. FASEB J 32(2):1070-1084 |
| abstractText | NOD-like receptor family caspase recruitment domain family domain containing 5 (NLRC5) has important roles in inflammation and innate immunity. NLRC5 was highly expressed in kidney from streptozotocin-induced diabetic mice, db/ db mice and patients with diabetes. Based on that evidence, the present study was designed to explore the roles of NLRC5 in the progression of diabetic nephropathy (DN). We examined kidney injury, including inflammation and fibrosis in Nlrc5 gene knockout ( Nlrc5(-/-)) and wild-type (WT) diabetic mice. We found that Nlrc5(-/-) mice developed less-severe diabetic kidney injury compared with WT mice, exhibiting lower albuminuria, less fibronectin and collagen IV expression, and reduced macrophage infiltration but greater levels of podocin and nephrin in the diabetic kidney. The underlying mechanisms were further investigated in vitro with peritoneal macrophages and mesangial cells treated with high glucose. Reduced proinflammatory effect was observed in peritoneal macrophages from Nlrc5(-/-) mice, associated with NF-kappaB pathway suppression. Knocking down of NLRC5 in mesangial cells in high-glucose conditions was also associated with reduced NF-kappaB and TGF-beta/Smad signaling. Taken together, NLRC5 promotes inflammation and fibrosis during DN progression partly through the effects on NF-kappaB and TGF-beta/Smad pathways. NLRC5 may, therefore, be a promising therapeutic target for DN treatment.-Luan, P., Zhuang, J., Zou, J., Li, H., Shuai, P., Xu, X., Zhao, Y., Kou, W., Ji, S., Peng, A., Xu, Y., Su, Q., Jian, W., Peng, W. NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation. |
